The TGA has published updated information for nitrosamine impurities in medicines consistent with recent EMA updated ...

The discovery of nitrosamine impurities in commonly prescribed drugs prompted regulatory authorities to implement a rapid response. The US Food and Drug Administration (FDA) and European Medicines ...

Nitrosamine impurities are byproducts produced in trace amounts during the manufacturing processes of angiotensin receptor blocking (ARB) medications. However, these impurities are classified as ...

Controlling and monitoring impurities in APIs and finished drug products is a crucial issue in drug development and manufacturing. Part I of this article, published in the February 2012 issue of ...

Discussion Genotoxic impurities can occur in drug products based on the manufacturing of the API, degradation of the API, or in some cases, from the excipients (9). The source of genotoxic impurities ...

It can take 9 to 18 as much energy to produce aluminum from raw ore than melting down and purifying used and recycled aluminum. However, some of the impurities are hard to remove.